{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:19:57Z","timestamp":1791559197628,"version":"4.3.4"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To raise awareness among pediatric intensive care specialists of catecholaminergic polymorphic ventricular tachycardia; an uncommon cause of polymorphic ventricular tachycardia and ventricular fibrillation arrest in children and young adults where epinephrine (adrenaline), even when given according to international protocols, can be counter-productive and life-threatening. We review three cases of cardiac arrest in children, later proven to be catecholaminergic polymorphic ventricular tachycardia related, where delay in recognition of this condition resulted in significantly longer resuscitation efforts, more interventions, and a longer time to return of spontaneous circulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Retrospective case series.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Tertiary children\u2019s hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Results:<\/jats:title>\n                    <jats:p>Three previously well children 4, 5, and 10 years old presented with cardiac arrest triggered by light activity, partial water immersion, and running, respectively. Initial resuscitation was bystander cardiopulmonary resuscitation and community defibrillation in all three cases. Electrocardiograms revealed multifocal ventricular ectopy, and in two (4 and 10 yr old), this correlated with repeated administration of epinephrine during repeated ventricular tachycardia and ventricular fibrillation cardiac arrest resuscitation cycles. This ultimately resolved immediately (at 78 and 140\u2009min, respectively) with IV opiates once catecholaminergic polymorphic ventricular tachycardia was suspected. During recovery, on extracorporeal membrane oxygenation, epinephrine challenge in two children induced polymorphic ventricular tachycardia, bidirectional ventricular tachycardia, and ventricular fibrillation, which was cardioverted with flecainide in the 4-year-old. The third case was recognized early as catecholaminergic polymorphic ventricular tachycardia and was managed by avoiding epinephrine and using opiates and general anesthesia after the initial (single) cardioversion, and had a much better clinical course, without recourse to extracorporeal membrane oxygenation. All three carried de novo RyR2 (cardiac ryanodine) mutations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Those involved in resuscitation of young people should be aware of catecholaminergic polymorphic ventricular tachycardia and be suspicious of persistent ventricular ectopy, polymorphic, or bidirectional ventricular tachycardia during resuscitation. Appropriate management is avoidance of epinephrine, administration of general anesthesia, IV opiates, and consideration of flecainide.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/pcc.0000000000001847","type":"journal-article","created":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T03:47:31Z","timestamp":1547869651000},"page":"262-268","source":"Crossref","is-referenced-by-count":32,"title":["Catecholaminergic Polymorphic Ventricular Tachycardia: The Cardiac Arrest Where Epinephrine Is Contraindicated*"],"prefix":"10.1097","volume":"20","author":[{"given":"David","family":"Bellamy","sequence":"first","affiliation":[{"name":"Green Lane Paediatric and Congenital Cardiac Services, Starship Children\u2019s Hospital, Auckland, New Zealand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Nuthall","sequence":"additional","affiliation":[{"name":"Paediatric Intensive Care Unit, Starship Children\u2019s Hospital, Auckland, New Zealand."},{"name":"Department of Paediatrics Child and Youth Health, the University of Auckland, Auckland, New Zealand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Dalziel","sequence":"additional","affiliation":[{"name":"Children\u2019s Emergency Department, Starship Children\u2019s Hospital, Auckland, New Zealand."},{"name":"Departments of Surgery and Paediatrics: Child and Youth Health, the University of Auckland, Auckland, New Zealand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Skinner","sequence":"additional","affiliation":[{"name":"Green Lane Paediatric and Congenital Cardiac Services, Starship Children\u2019s Hospital, Auckland, New Zealand."},{"name":"Departments of Surgery and Paediatrics: Child and Youth Health, the University of Auckland, Auckland, New Zealand."},{"name":"Cardiac Inherited Disease Group, Auckland City Hospital, Auckland, New Zealand."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230823","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/CIRCEP.111.962027","article-title":"Catecholaminergic polymorphic ventricular tachycardia.","volume":"5","author":"Leenhardt","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R2-20230823","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/heartjnl-2016-311025","article-title":"Catecholaminergic polymorphic tachycardia: Underestimated and overtreated?","volume":"103","author":"Pflaumer","year":"2017","journal-title":"Heart"},{"key":"R3-20230823","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.jacc.2017.02.046","article-title":"Utility of post-mortem genetic testing in cases of sudden arrhythmic death syndrome.","volume":"69","author":"Lahrouchi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R4-20230823","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa1510687","article-title":"A prospective study of sudden cardiac death among children and young adults.","volume":"374","author":"Bagnall","year":"2016","journal-title":"N Engl J Med"},{"key":"R5-20230823","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1023\/A:1017999408452","article-title":"Catecholaminergic polymorphic ventricular tachyarrhythmias in children.","volume":"6","author":"Coumel","year":"2002","journal-title":"Card Electrophysiol Rev"},{"key":"R6-20230823","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1161\/CIRCULATIONAHA.111.055947","article-title":"Sudden cardiac death and genetic ion channelopathies: Long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation.","volume":"125","author":"Napolitano","year":"2012","journal-title":"Circulation"},{"key":"R7-20230823","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1017\/S1047951116002237","article-title":"Advances in the diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia.","volume":"27","author":"Roston","year":"2017","journal-title":"Cardiol Young"},{"key":"R8-20230823","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/europace\/euw389","article-title":"The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: Findings from an international multicentre registry.","volume":"20","author":"Roston","year":"2018","journal-title":"Europace"},{"key":"R9-20230823","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.hrthm.2011.01.048","article-title":"Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.","volume":"8","author":"Sy","year":"2011","journal-title":"Heart Rhythm"},{"key":"R10-20230823","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1161\/CIRCULATIONAHA.105.552166","article-title":"Diagnosis of unexplained cardiac arrest: Role of adrenaline and procainamide infusion.","volume":"112","author":"Krahn","year":"2005","journal-title":"Circulation"},{"key":"R11-20230823","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/archdischild-2011-301515","article-title":"Investigation following resuscitated cardiac arrest.","volume":"98","author":"Skinner","year":"2013","journal-title":"Arch Dis Child"},{"key":"R12-20230823","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.hrthm.2008.09.013","article-title":"Molecular basis of catecholaminergic polymorphic ventricular tachycardia.","volume":"6","author":"Gy\u00f6rke","year":"2009","journal-title":"Heart Rhythm"},{"key":"R13-20230823","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/CIRCEP.115.003159","article-title":"Physical and psychological consequences of left cardiac sympathetic denervation in long-QT syndrome and catecholaminergic polymorphic ventricular tachycardia.","volume":"8","author":"Waddell-Smith","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R14-20230823","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jacc.2011.01.026","article-title":"Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.","volume":"57","author":"van der Werf","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R15-20230823","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCEP.114.002217","article-title":"Catecholaminergic polymorphic ventricular tachycardia in children: Analysis of therapeutic strategies and outcomes from an international multicenter registry.","volume":"8","author":"Roston","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R16-20230823","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nm.1942","article-title":"Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans.","volume":"15","author":"Watanabe","year":"2009","journal-title":"Nat Med"},{"key":"R17-20230823","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa0708006","article-title":"Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia.","volume":"358","author":"Wilde","year":"2008","journal-title":"N Engl J Med"},{"key":"R18-20230823","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.hrthm.2013.10.027","article-title":"Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.","volume":"11","author":"Roses-Noguer","year":"2014","journal-title":"Heart Rhythm"},{"key":"R19-20230823","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1161\/CIR.0000000000000273","article-title":"Part 4: Advanced Life Support: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.","volume":"132","author":"Callaway","year":"2015","journal-title":"Circulation"},{"key":"R20-20230823","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.resuscitation.2015.07.016","article-title":"European Resuscitation Council Guidelines for Resuscitation 2015: Section 3. Adult advanced life support.","volume":"95","author":"Soar","year":"2015","journal-title":"Resuscitation"},{"key":"R21-20230823","first-page":"S177","article-title":"Part 6: Pediatric Basic Life Support and Pediatric Advanced Life Support: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.","volume":"132","author":"de Caen","year":"2015","journal-title":"Circulation"},{"key":"R22-20230823","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.resuscitation.2015.07.028","article-title":"European Resuscitation Council Guidelines for Resuscitation 2015: Section 6. Paediatric life support.","volume":"95","author":"Maconochie","year":"2015","journal-title":"Resuscitation"},{"key":"R23-20230823","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.CIR.91.5.1512","article-title":"Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients.","volume":"91","author":"Leenhardt","year":"1995","journal-title":"Circulation"},{"key":"R24-20230823","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.hlc.2011.10.008","article-title":"Guidelines for the diagnosis and management of catecholaminergic polymorphic ventricular tachycardia.","volume":"21","author":"Pflaumer","year":"2012","journal-title":"Heart Lung Circ"},{"key":"R25-20230823","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.hrthm.2006.12.048","article-title":"Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia.","volume":"4","author":"Napolitano","year":"2007","journal-title":"Heart Rhythm"},{"key":"R26-20230823","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jacc.2009.03.086","article-title":"Bidirectional ventricular tachycardia.","volume":"54","author":"Richter","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R27-20230823","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/PEC.0000000000001156","article-title":"Catecholaminergic polymorphic ventricular tachycardia.","volume":"33","author":"Wall","year":"2017","journal-title":"Pediatr Emerg Care"},{"key":"R28-20230823","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/1751143717732729","article-title":"Sudden cardiac arrest in hypertrophic cardiomyopathy with dynamic cavity obstruction: The case for a decatecholaminisation strategy.","volume":"19","author":"Balan","year":"2018","journal-title":"J Intensive Care Soc"},{"key":"R29-20230823","first-page":"320","article-title":"Paradoxical and severe hypotension in response to adrenaline infusions in massive quetiapine overdose.","volume":"10","author":"Hawkins","year":"2008","journal-title":"Crit Care Resusc"},{"key":"R30-20230823","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.hrthm.2006.07.018","article-title":"Digital implantable loop recorders in the investigation of syncope in children: Benefits and limitations.","volume":"3","author":"Kothari","year":"2006","journal-title":"Heart Rhythm"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00130478-201903000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T20:44:40Z","timestamp":1692823480000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130478-201903000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000001847","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}